These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18982724)

  • 1. [The treatment of neurospastic vascular diseases in Raynaud phenomenon].
    Buryĭ VT; Buryĭ VV
    Klin Khir; 2008 Jun; (6):36-9. PubMed ID: 18982724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of spinal cord stimulation in Raynaud's Phenomenon: can subthreshold sensory stimulation have an effect?
    Benyamin R; Kramer J; Vallejo R
    Pain Physician; 2007 May; 10(3):473-8. PubMed ID: 17525782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iloprost treatment in pediatric patients with complicated Raynaud's phenomenon.
    Cekic S; Kilic SS
    Lupus; 2016 Apr; 25(5):558-60. PubMed ID: 26692039
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of vasodilator agents and of indirect heating in Raynaud's disease.
    Hansteen V
    Scand J Clin Lab Invest Suppl; 1973; 128():211-2. PubMed ID: 4764583
    [No Abstract]   [Full Text] [Related]  

  • 5. Raynaud's Phenomenon.
    Wigley FM; Flavahan NA
    N Engl J Med; 2016 Aug; 375(6):556-65. PubMed ID: 27509103
    [No Abstract]   [Full Text] [Related]  

  • 6. Spinal cord stimulation in vibration white finger.
    Sciacca V; Petrakis I; Borzomati V
    Vasa; 1998 Nov; 27(4):247-9. PubMed ID: 9859748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raynaud, digital ulcers and calcinosis in scleroderma.
    Nitsche A
    Reumatol Clin; 2012; 8(5):270-7. PubMed ID: 22835924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of superficial electric stimulation as a factor preventing marked decrease in skin temperature in various diseases of the peripheral blood vessels].
    Szczypiorski P; Kruk M; Borkowski M; Szamowska R
    Pol Tyg Lek; 1985 Aug; 40(32):896-900. PubMed ID: 3877274
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of botulinum toxin in vasospastic disorders of the hand.
    Neumeister MW
    Hand Clin; 2015 Feb; 31(1):23-37. PubMed ID: 25455354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thermographic evaluation of the effectiveness of electric surface stimulation on skin microcirculation in various peripheral vascular diseases].
    Kruk M; Szczypiorski P; Borkowski M; Szamowska R
    Pol Tyg Lek; 1985 Apr; 40(17):485-9. PubMed ID: 3874397
    [No Abstract]   [Full Text] [Related]  

  • 11. [Physiological basis of the action of surface electrostimulation in the treatment of various vascular diseases].
    Szczypiorski P; Borkowski M; Jeziorski KG
    Pol Tyg Lek; 1985 Mar; 40(10):313-6. PubMed ID: 3889881
    [No Abstract]   [Full Text] [Related]  

  • 12. A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon.
    Hummers LK; Dugowson CE; Dechow FJ; Wise RA; Gregory J; Michalek J; Yenokyan G; McGready J; Wigley FM
    Ann Rheum Dis; 2013 Dec; 72(12):1962-7. PubMed ID: 23268365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of the plethysmographic amplification factor during vasodilator treatment. Healthy subject versus primary Raynaud phenomenon].
    Lasfargues G; Royere D; Perrotin D; Titon JP; Soutif D; Guilmot JL
    J Mal Vasc; 1987; 12(4):319-22. PubMed ID: 3694055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of alpha-adrenergic blockade in the cardiovascular actions of ketanserin: studies in patients with essential hypertension, autonomic insufficiency, and Raynaud's phenomenon.
    Brouwer RM; Wenting GJ; Man in't Veld AJ; Schalekamp MA
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S26-31. PubMed ID: 2446064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Laser Doppler spectral analysis of patients with Raynaud's phenomenon during a standardized thermal test].
    Léger P
    Ann Dermatol Venereol; 1998 Nov; 125 Suppl 2():S28-9. PubMed ID: 9922888
    [No Abstract]   [Full Text] [Related]  

  • 16. Pain relief following post-ganglionic sympathetic blockade with I.V. guanethidine.
    Glynn CJ; Basedow RW; Walsh JA
    Br J Anaesth; 1981 Dec; 53(12):1297-302. PubMed ID: 7317248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rheographic evaluation of the changes in blood flow after superficial electric stimulation in patients with Raynaud's disease or syndrome].
    Kruk M; Borkowski M; Wojtal E; Górewicz R
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):921-3. PubMed ID: 2487760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acral ischemia (Raynaud's phenomenon) in nervous system and vascular compression-stretching syndromes in the thoracic outlet syndrome].
    Beaujean MA; Bodson L
    Rev Med Liege; 1980 Oct; 35(19):645-50. PubMed ID: 7455447
    [No Abstract]   [Full Text] [Related]  

  • 19. 25. Ischemic pain in the extremities and Raynaud's phenomenon.
    Devulder J; van Suijlekom H; van Dongen R; Diwan S; Mekhail N; van Kleef M; Huygen F
    Pain Pract; 2011; 11(5):483-91. PubMed ID: 21435165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of tadalafil on cold-induced vasoconstriction in patients with Raynaud's phenomenon.
    Friedman EA; Harris PA; Wood AJ; Stein CM; Kurnik D
    Clin Pharmacol Ther; 2007 Apr; 81(4):503-9. PubMed ID: 17301734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.